2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazole
Structure Info
- Chemspace ID
- CSSB03552306897 (In-Stock Building Blocks)
- MFCD
- MFCD35781664
- IUPAC Name
- 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazole
- Mol formula
- C14H17BN2O2S
- Mol weight
- 288 Da
- Catalog Number(s)
- BBLS03552306897, BBV-397511158, EN300-34521865, bbls03552306897
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.11
- Heavy atoms count
- 20
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.42857142857143
- Polar surface area (Å)
- 44
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazole (C14H17BN2O2S) - CSSB03552306897](/st/structure/200/2e677ca884259461fda77c1ef79a2177/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cccc%2528c2%2529c3nncs3.png "C14H17BN2O2S")
- Zoom the structure
- CSSB03552306897
Items Overall 30 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 105.63 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 149.30 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 206.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 261.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 323.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 186.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 277.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 396.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 624.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 800.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 1,568.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 2,318.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 10 g | 3,438.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 50 mg | 186.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 100 mg | 277.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 250 mg | 396.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 500 mg | 624.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 1 g | 800.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 2.5 g | 1,568.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 186.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 277.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 396.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 624.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 800.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 1,568.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 105.63 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 149.30 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 206.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 261.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 323.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole - CSSB00010365631](/st/structure/200/2a3b8b46e31bdb18ac6f78e33933976f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%253DCS1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazole - CSSB03552306896](/st/structure/200/0c693a6cfddce806a10089813ad0c1c5/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2ccc%2528cc2%2529c3nncs3.png)
![Chemical structure of 4-methyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole - CSSB06262272099](/st/structure/200/045ed52e488ebca1996248f0f1f68b6b/Cc1csc%2528n1%2529c2cccc%2528c2%2529B3OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O3.png)
![Chemical structure of 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4H-1,2,4-triazole - CSSB00021308312](/st/structure/200/1dac802b638bb4826404a11e5b9b0f4b/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNN%253DCN1.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010144809](/st/structure/200/493e98023a91f6d044789a829f1f6afd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2,4-thiadiazole - CSSB06584800732](/st/structure/200/d1a8bc97046a816f3fc3637b843e991b/CC1%2528C%2529OB%2528C2%253DCC%2528C3%253DNC%253DNS3%2529%253DCC%253DC2%2529OC1%2528C%2529C.png)
![Chemical structure of 2-methyl-4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole - CSSB06584798443](/st/structure/200/0e96b9a4b4cd4002d237799d16d0dd7b/CC1%253DNC%2528C2%253DCC%253DCC%2528B3OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O3%2529%253DC2%2529%253DCS1.png)
